Journal
RADIOLOGIC CLINICS OF NORTH AMERICA
Volume 51, Issue 5, Pages 865-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rcl.2013.06.004
Keywords
Melanoma; PET; CT; Cutaneous melanoma
Ask authors/readers for more resources
Fludeoxyglucose F 18 positron emission tomography/computed tomography (PET/CT) has been invaluable in the assessment of melanoma throughout the course of the disease. As with any modality, the studies are incomplete and more information will be gleaned as our experience progresses. Additionally, it is hoped that a newer PET agent in the pipeline will give us even greater success in the identification and subsequent treatment of melanoma. This article aims to examine the utilization of PET/CT in the staging, prognostication, and follow-up of melanoma while providing the physicians who order and interpret these studies practical guidelines and interpretive pitfalls.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available